Last data update: Aug 10, 2022. (Total: 3965 publications since 2011)
|Query Trace: all>>C H Miller[CDC Author]|
| Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
B Boylan, A S Rice, C De Staercke, M E Eyster, H M Yaish, C M Knoll, C J Bean, C H Miller, and
J. Thromb. Haemost. 2015 Jun 13(6) 1036-42
Similar articles in PubMed DOI:10.1111/jth.12902
| Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening.
A B Payne, C J Bean, W C Hooper, and C H Miller
J. Thromb. Haemost. 2012 Sep 10(9) 1951-4
Similar articles in PubMed DOI:10.1111/j.1538-7836.2012.04843.x
| F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
C H Miller, J Benson, D Ellingsen, J Driggers, A Payne, F M Kelly, J M Soucie, W Craig Hooper, and
Haemophilia 2012 May 18(3) 375-82
Similar articles in PubMed DOI:10.1111/j.1365-2516.2011.02700.x